跳至主要内容
临床试验/CTRI/2021/02/031096
CTRI/2021/02/031096尚未招募未知

CD4 cell counts as a prognostic bio marker in Covid 19 infection in hospitalised patients - CD4 counts in Covid 19

Government Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patient diagnosed as covid 19 infected either by RTPCR or Rapid antigen test.
  • Patients diagnosed as Covid 19 positive will be divided into Group A and Group B as per Revised Guidelines on Clinical Management of COVID â?? 19. Ministry of Health & Family Welfare Directorate General of Health Services (EMR Division) Government of India. (12)
  • Group A â?? RT PCR or RAT positive
  • Severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock will be considered as severe Covid infection
  • Group B - RT PCR or RAT positive
  • Uncomplicated illness and mild pneumonia will be considered as non-severe (mild/moderate) Covid infection

排除标准

  • HIV infected patients
  • Patients on immunosuppressive therapy or any disease or therapy known to affect the CD4 counts e.g. autoimmune disease, tuberculosis, patients on chronic steroids, etc

研究者

相似试验